Reuters logo
BRIEF-Laurus Labs gets EIR from U.S. FDA for plant at unit 2 in Atchutapuram
September 15, 2017 / 10:07 AM / 7 days ago

BRIEF-Laurus Labs gets EIR from U.S. FDA for plant at unit 2 in Atchutapuram

Sept 15 (Reuters) - Laurus Labs Ltd

* Gets EIR from U.S. FDA for its finished dosage formulations & active pharmaceutical ingredients plant, unit 2, located at Atchutapuram

* Unit 2 (FDF) completed BGV Hamburg inspection, units 1 & 3 completed WHO inspection this month with no critical/major observations Source text - bit.ly/2h6TOZm Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below